Prof. Dr. med. Carola Berking



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma (2022) Koch E, Schaft N, Kummer M, Berking C, Schuler G, Hasumi K, Dörrie J, Schuler-Thurner B Journal article Soluble CD83 promotes cutaneous wound healing in an IDO-and beta-catenindependent manner (2022) Royzman D, Peckert-Maier K, Stich L, Wild A, Ostalecki C, Kiesewetter F, Seyferth S, et al. Conference contribution Dissecting the IFN gamma-mediated transcriptomic alterations in Merkel cell carcinoma cell lines using Nanopore sequencing (2022) Sauerer T, Lischer C, Berking C, Vera González J, Dörrie J Conference contribution Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity (2022) Koch E, Petzold A, Wessely A, Dippel E, Gesierich A, Gutzmer R, Hassel JC, et al. Journal article Onkologische Systemtherapie bis zum bitteren Ende? (2022) Berking C Journal article Are YouTube videos on cutaneous squamous cell carcinoma a useful and reliable source for patients? (2022) Reinhardt L, Steeb T, Harlaß M, Brütting J, Meier F, Berking C Journal article, Letter Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment. (2022) Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L, Gesierich A, et al. Journal article Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study. (2022) Simon D, Tascilar K, Fagni F, Kleyer A, Krönke G, Meder C, Dietrich P, et al. Journal article Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma. (2022) Schuler M, Zimmer L, Kim KB, Sosman JA, Ascierto PA, Postow MA, De Vos FY, et al. Journal article The need for regular training in skin cancer screening: a cross-sectional study among general practitioners in Germany (2022) Steeb T, Reinhardt L, Strasser C, Wessely A, Schelling J, Petzold A, Heppt M, et al. Journal article